-
公开(公告)号:US10888230B2
公开(公告)日:2021-01-12
申请号:US15868623
申请日:2018-01-11
Inventor: Eric J. Seibel , Leonard Y. Nelson
IPC: A61B5/00 , G01J3/02 , G01J3/06 , G01J3/44 , G01J3/10 , G01N21/64 , A61B1/00 , A61B1/015 , A61B1/07 , A61B1/247 , A61C19/04
Abstract: Methods and systems for detecting early stage dental caries and decays are provided. In particular, in an embodiment, laser-induced autofluorescence (AF) from multiple excitation wavelengths is obtained and analyzed. Endogenous fluorophores residing in the enamel naturally fluoresce when illuminated by wavelengths ranging from ultraviolet into the visible spectrum. The relative intensities of the AF emission changes between different excitation wavelengths when the enamel changes from healthy to demineralized. By taking a ratio of AF emission spectra integrals between different excitation wavelengths, a standard is created wherein changes in AF ratios within a tooth are quantified and serve as indicators of early stage enamel demineralization. The techniques described herein may be used in conjunction with a scanning fiber endoscope (SFE) to provide a reliable, safe and low-cost means for identifying dental caries or decays.
-
公开(公告)号:US20200277336A1
公开(公告)日:2020-09-03
申请号:US16806617
申请日:2020-03-02
Inventor: Andre LIEBER , Hongjie WANG
Abstract: The present invention provides recombinant adenoviral compositions and methods for their use in treating disorders associated with epithelial tissues.
-
33.
公开(公告)号:US20200276294A1
公开(公告)日:2020-09-03
申请号:US16595288
申请日:2019-10-07
Inventor: Michael J. Gale, JR. , Gretja Schnell , Yueh-Ming Loo
Abstract: Compositions and methods are provided that enable activation of innate immune responses through RIG-I like receptor signaling. The compositions and methods incorporate synthetic nucleic acid pathogen associated molecular patterns (PAMPs) that comprise elements initially characterized in, and derived from, the hepatitis C virus genome.
-
34.
公开(公告)号:US10752951B2
公开(公告)日:2020-08-25
申请号:US16514931
申请日:2019-07-17
Inventor: Jesse Salk , Lawrence A. Loeb , Michael Schmitt
IPC: C12Q1/68 , C12Q1/6876 , C12Q1/6806 , C12Q1/6869
Abstract: Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand. This method uniquely capitalizes on the redundant information stored in double-stranded DNA, thus overcoming technical limitations of prior methods utilizing data from only one of the two strands.
-
公开(公告)号:US10751050B2
公开(公告)日:2020-08-25
申请号:US14408244
申请日:2013-06-17
Inventor: Marco Rolandi , Vittorio Ruvolo , Ronald J. Berenson , Chase Ruebel , Jungho Jin
Abstract: The present invention relates generally to wound closure devices comprising one or more microstructures. The devices are designed such that the microstructures are able to grip the skin or tissue surrounding a wound, optionally closing the wound, or securing the tissue or skin in place. Also provided are wound closure systems that comprise one or more microstructure wound closure devices along with other components, such as protective covers and wound healing therapeutics. A variety of packaging specifications are disclosed, as is a dispenser apparatus configured to enable simple one-handed application of the wound closure devices. Methods described herein provide for the closure of various wounds with the wound closure devices and systems.
-
公开(公告)号:US20200157615A1
公开(公告)日:2020-05-21
申请号:US16783037
申请日:2020-02-05
Inventor: Daniel T. CHIU , Bryant S. FUJIMOTO , Alexander R. GANSEN , Gloria S. YEN , Robert M. LORENZ
IPC: C12Q1/6851 , C12Q1/6806
Abstract: Methods and systems for digital measurements are provided. In an embodiment, the method includes producing a plurality of droplets, wherein at least one of the droplets of the plurality of droplets contains an analyte molecule from a sample; measuring at least a first portion of the plurality of droplets to determine individual volumes of droplets in the first portion of the plurality of droplets; analyzing at least a second portion of the plurality of droplets to determine a number of droplets in the second portion of the plurality of droplets that contain the analyte molecule; and using individual volumes of the droplets in the first portion of the plurality of droplets and the number of droplets in the second portion of the plurality of droplets that contain the analyte molecule to determine the concentration of the analyte molecule in the sample.
-
37.
公开(公告)号:US10570451B2
公开(公告)日:2020-02-25
申请号:US16120019
申请日:2018-08-31
Inventor: Jesse Salk , Lawrence A. Loeb , Michael Schmitt
IPC: C12Q1/68 , C12Q1/6876 , C12Q1/6806 , C12Q1/6869
Abstract: Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand. This method uniquely capitalizes on the redundant information stored in double-stranded DNA, thus overcoming technical limitations of prior methods utilizing data from only one of the two strands.
-
公开(公告)号:US10562938B2
公开(公告)日:2020-02-18
申请号:US15692909
申请日:2017-08-31
Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION , THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
Inventor: Carlos Enrique Catalano , Jenny Ren-Jye Chang
Abstract: The present invention provides viral-based nanoparticles for therapeutic and diagnostic use, and methods for making and using the nanoparticles. Specifically, such nanoparticles comprise decoration-competent viral particles shells such as expanded capsids of phages, stabilized with engineered decoration proteins that have been linked to one or more compounds not naturally occurring on a wild type viral capsid.
-
公开(公告)号:US20200011874A1
公开(公告)日:2020-01-09
申请号:US16556006
申请日:2019-08-29
Inventor: Daniel T. Chiu , Changfeng Wu , Jiangbo Yu
Abstract: The present disclosure provides encoded chromophoric polymer particles that are capable of, for example, optical and/or biomolecular encoding of analytes. The present disclosure also provides suspensions comprising a plurality of encoded chromophoric polymer particles. The present disclosure also provides methods of using the encoded chromophoric polymer particles and systems for performing multiplex analysis with encoded chromophoric polymer particles.
-
公开(公告)号:US10463286B2
公开(公告)日:2019-11-05
申请号:US15430334
申请日:2017-02-10
Inventor: Kenneth Schenkman , Lorilee Arakaki , Wayne Ciesielski , Jeremy Shaver
IPC: A61B5/1455 , A61B5/00 , A61B5/145 , A61B90/00
Abstract: A system and method for noninvasively determining the oxygenation of a tissue, for example, a muscle, in vivo uses optical methods to optically interrogate the tissue in both a visible wavelength range and a near infrared (NIR) wavelength range. The illuminating light is sculpted in intensity to approximately match the absorbance spectrum, for example, with the visible light having an intensity an order of magnitude greater than the NIR light. Training data is obtained from healthy patients in both the visible and NIR ranges simultaneously and used to calculate muscle oxygenation.
-
-
-
-
-
-
-
-
-